Grade: F — Major Red Flags
Framework: Schilit *Financial Shenanigans* + Beneish M-Score + forensic accounting principles
Data: SEC EDGAR 10-K/A (Amendment filed 2026-03-17, FY ended December 31, 2025) + Yahoo Finance
Auditor: KPMG LLP — Unqualified opinion
One-line verdict: Mosaic's FY2025 screening triggers three red flags: inventory surging 32% while COGS rose only 5.6%, free cash flow negative at -$535M despite positive net income of $541M, and cash of $277M covering just 5% of $5.3B in total debt. Revenue rebounded 8.4% to $12.1B and gross margin improved to 15.8%, but the massive inventory build and CapEx-driven negative FCF suggest the company is investing heavily while generating inadequate free cash. The M-Score is clean at -2.68, meaning this isn't manipulation — it's a fertilizer business consuming cash to expand capacity during a cyclical trough.
| Metric | Result |
|---|---|
| :x: Red Flags | **3** (Inventory vs COGS, FCF, Cash-to-Debt) |
| :warning: Watch Items | **0** |
| Checks Completed | **17/18** (1 N/A: impairment data) |
| Beneish M-Score | **-2.68** (clean) |
| Altman Z-Score | **3.66** (safe zone) |
| Auditor | KPMG LLP — Unqualified opinion |
The Fertilizer Giant's Post-Boom Hangover
Mosaic is the world's largest combined phosphate and potash producer, operating primarily through two segments: Phosphates and Potash. The filing is a 10-K/A amendment, filed to "provide the disclosure in Part II, Item 5 regarding the number of shareholders of record" and to file a "revised Esterhazy Potash Facility Consent of Qualified Persons."
The core financial data tells a story of normalization from the FY2022 fertilizer super-cycle. Revenue peaked at $19.1B in FY2022, crashed to $11.1B in FY2024, and partially recovered to $12.1B in FY2025. Net income followed a similar trajectory: $3.6B (FY2022) to $175M (FY2024) to $541M (FY2025).
Profitability: Recovery from the Bottom
| Metric | FY2022 | FY2023 | FY2024 | FY2025 | Trend |
|---|---|---|---|---|---|
| Revenue | $19.1B | $13.7B | $11.1B | $12.1B | +8.4% recovery |
| Net Income | $3.6B | $1.2B | $175M | $541M | Recovering |
| Gross Margin | 30.1% | 16.1% | 13.6% | 15.8% | Modestly expanding |
| Net Margin | 18.7% | 8.5% | 1.6% | 4.5% | Thin |
| ROE | 29.7% | 9.5% | 1.5% | 4.5% | Low |
Gross margin improved 2.2 percentage points to 15.8%, suggesting pricing is stabilizing. But net margin of 4.5% is thin for a commodity producer, and ROE of 4.5% is well below cost of capital.
Cash Flow: The Core Concern
| Metric | FY2023 | FY2024 | FY2025 |
|---|---|---|---|
| Operating Cash Flow | $2.4B | $1.3B | $825M |
| Net Income | $1.2B | $175M | $541M |
| CFFO / NI | 2.07 | 7.43 | 1.53 |
| CapEx | $1.4B | $1.3B | $1.4B |
| Free Cash Flow | $1.0B | $47M | -$535M |
This is the heart of the problem. Operating cash flow of $825M is respectable, but CapEx of $1.4B far exceeds it, producing negative free cash flow of -$535M. The CFFO/NI ratio of 1.53 shows profits are backed by cash, but the company is spending more than it earns on capital projects.
CapEx of $1.4B against revenue of $12.1B represents 11.5% capital intensity — typical for mining but dangerous when combined with thin margins and declining operating cash flow. The company is betting that current investment will generate future returns, but in the meantime shareholders are subsidizing growth through balance sheet deterioration.
The 18-Point Screening
Revenue Quality
| # | Check | Result | Detail |
|---|---|---|---|
| A1 | DSO Change | :white_check_mark: | DSO 29 days, -5 days YoY |
| A2 | AR vs Revenue Growth | :white_check_mark: | AR -6.4% vs revenue +8.4% |
| A3 | Revenue vs CFFO | :white_check_mark: | Revenue +8.4%, CFFO -36.5% |
Revenue quality is clean. Receivables actually declined while revenue grew — suggesting no aggressive revenue recognition.
Expense Quality
| # | Check | Result | Detail |
|---|---|---|---|
| B1 | Inventory vs COGS | :x: | Inventory +32.0% vs COGS +5.6% |
| B2 | CapEx vs Revenue | :white_check_mark: | CapEx +8.6% vs revenue +8.4% |
| B3 | SG&A Ratio | :white_check_mark: | SG&A/Gross Profit = 28.1%, excellent |
| B4 | Gross Margin | :white_check_mark: | 15.8%, +2.2pp, stable |
B1 is a red flag. Inventory surging 32% while cost of goods sold rose only 5.6% is a classic warning signal in the Schilit framework. In a fertilizer company, this could mean: (a) product is not selling as fast as expected, (b) the company is building strategic stockpiles anticipating higher prices, or (c) input costs dropped and the company is pre-purchasing raw materials. Given that gross margin improved, scenario (b) or (c) is more likely than unsaleable product — but the divergence is large enough to demand monitoring.
Cash Flow Quality
| # | Check | Result | Detail |
|---|---|---|---|
| C1 | CFFO vs Net Income | :white_check_mark: | CFFO/NI = 1.53, profits backed by cash |
| C2 | Free Cash Flow | :x: | FCF negative at -$535M |
| C3 | Accruals Ratio | :white_check_mark: | -1.2%, low accruals |
| C4 | Cash vs Debt | :x: | Cash $277M covers only 5% of debt $5.3B |
C2 and C4 are both failures. Negative free cash flow for two consecutive years (FY2024 barely positive at $47M) means the company is consuming more capital than it generates. Cash of $277M against $5.3B in debt is dangerously thin — Mosaic has amended and restated its credit agreement as recently as May 2025, securing a revolving credit facility, but any disruption to credit access would be immediately problematic.
Balance Sheet
| # | Check | Result | Detail |
|---|---|---|---|
| D1 | Goodwill + Intangibles | :white_check_mark: | $1.0B = 8% of equity |
| D2 | Leverage | :white_check_mark: | Debt/EBITDA = 2.1x, healthy |
| D3 | Soft Asset Growth | :white_check_mark: | Other assets +5.4% vs revenue +8.4% |
| D4 | Asset Impairment | — | No write-off data available |
Leverage at 2.1x Debt/EBITDA is manageable, and the Z-Score of 3.66 places Mosaic in the safe zone. The debt load is serviceable — it's the cash position and CapEx pace that create the stress.
Acquisition Risk
| # | Check | Result | Detail |
|---|---|---|---|
| E1 | Serial Acquirer FCF | :white_check_mark: | FCF after acquisitions positive |
| E2 | Goodwill Surge | :white_check_mark: | Goodwill+Intangibles -5% YoY |
No acquisition-related concerns. Goodwill is modest and stable.
Manipulation Score
| # | Check | Result | Detail |
|---|---|---|---|
| F1 | Beneish M-Score | :white_check_mark: | -2.68 (clean) |
All M-Score components are benign. The books are honest — the problems are operational and structural.
Key Risks from the 10-K
1. Fertilizer Pricing Remains Depressed
Revenue has declined 37% from the FY2022 peak of $19.1B to $12.1B in FY2025. While prices stabilized in FY2025, they remain far below cycle highs. Mosaic's margins are highly sensitive to phosphate and potash commodity prices, and another leg down would push the company back toward breakeven.
2. Environmental Consent Decrees
The filing references consent decrees with the U.S. government and both the Florida Department of Environmental Protection and Louisiana Department of Environmental Quality, dating to September 2015. These impose ongoing remediation and compliance obligations on Mosaic's phosphate mining operations, representing recurring environmental expenditure commitments.
3. Negative Free Cash Flow Trajectory
Two consecutive years of near-zero or negative FCF while maintaining heavy CapEx is unsustainable without either: (a) higher commodity prices that lift operating cash flow, or (b) a reduction in capital spending. The company must thread a needle between investing for future capacity and maintaining financial flexibility.
4. Geographic and Political Risk
With operations in Florida, Louisiana, New Mexico, Saskatchewan (Canada), and Brazil (through its Mosaic Fertilizantes operations), Mosaic faces diverse regulatory, tax, and political risks across multiple jurisdictions.
Summary
Grade: F. Three red flags driven by inventory build, negative FCF, and thin cash coverage.
Mosaic's M-Score is clean, leverage is moderate at 2.1x, and the Z-Score signals no near-term distress. The problems are specific: a 32% inventory surge that demands explanation, CapEx spending that exceeds operating cash flow, and minimal cash against $5.3B in debt. The company is in the trough of a fertilizer pricing cycle and is investing for recovery — but if prices don't recover, the balance sheet deterioration will accelerate.
Watch for: (a) inventory levels in FY2026 — if they continue to build while margins stay flat, the B1 flag becomes more concerning, and (b) whether CapEx moderates to bring FCF back to positive territory.
**Disclaimer**: This report is based on Mosaic's FY2025 10-K/A filed with SEC EDGAR on March 17, 2026. This is NOT investment advice.
Data: SEC EDGAR 10-K/A + Yahoo Finance
Auditor: KPMG LLP (Unqualified opinion)
Fiscal year ended: December 31, 2025